DrugPatentWatch Database Preview

CLINDAGEL Drug Profile

Email this page to a colleague

« Back to Dashboard

When do Clindagel patents expire, and what generic alternatives are available?

Clindagel is a drug marketed by Bausch and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in twenty-two countries.

The generic ingredient in CLINDAGEL is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

US ANDA Litigation and Generic Entry Outlook for Clindagel

A generic version of CLINDAGEL was approved as clindamycin phosphate by ALVOGEN INC on July 24^th, 1987.

Summary for CLINDAGEL

International Patents:	34
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	42
Clinical Trials:	1
Patent Applications:	1,273
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CLINDAGEL
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CLINDAGEL
DailyMed Link:	CLINDAGEL at DailyMed

See drug prices for CLINDAGEL

See drug sales revenues for CLINDAGEL

Recent Clinical Trials for CLINDAGEL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GlaxoSmithKline	Phase 1
Stiefel, a GSK Company	Phase 1

See all CLINDAGEL clinical trials

Recent Litigation for CLINDAGEL

Identify potential future generic entrants

District Court Litigation

Case Name	Date
Bayer Healthcare Pharmaceuticals, Inc. v. River's Edge Pharmaceuticals, LLC	2011-05-19
Medicis Pharmaceutical Corporation v. Actavis Mid Atlantic LLC	2011-05-11
Medicis Pharmaceutical Corporation v. Acella Pharmaceuticals, LLC	2010-08-19

See all CLINDAGEL litigation

Pharmacology for CLINDAGEL

Drug Class	Lincosamide Antibacterial
Physiological Effect	Decreased Sebaceous Gland Activity

Synonyms for CLINDAGEL

(2S-trans)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-.alpha.-D-galacto-octopyranoside 2-(dihydrogen phosphate)

[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate

[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate

24729-96-2

7(S)-Chloro-7-deoxylincomycin 2-phosphate

AB01566857_01

AKOS008901431

API0002056

AS-12554

AX8019646

BDBM241975

BRD-K27771035-001-02-5

C11728

C18H34ClN2O8PS

CAS-24729-96-2

CHEMBL3184512

Cleocin phosphate

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Cleocin T

Clinda-Derm

Clindamax

Clindamycin (phosphate)

Clindamycin 2-dihydrogen phosphate

Clindamycin 2-phosphate

Clindamycin dihydrogenphosphat

Clindamycin injection

Clindamycin phosphate

Clindamycin phosphate (JP17/USP)

Clindamycin phosphate [USAN:JAN]

Clindamycin phosphate [USAN:USP:JAN]

CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%

CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Clindamycin-2-dihydrogenphosphat

CLINDAMYCIN-2-PHOSPHATE

clindamycin-phosphate

Clindesse

Clindets

CS-4620

D01073

Dalacin P

Dalacin T

Dalacin-S (TN)

DSSTox_CID_28603

DSSTox_GSID_48677

DSSTox_RID_82873

DTXSID1048677

EH6D7113I8

EINECS 246-433-0

Evoclin

Evoclin (TN)

HY-B1064

L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-

L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-

LS-98133

Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate)

Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2- pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)

Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)

MFCD07793328

NCGC00163494-01

NCGC00166320-01

NCGC00386379-01

NSC 618653

NSC-618653

PubChem5913

Q27106184

s2048

SCHEMBL37148

SR-01000872581

SR-01000872581-1

ST24046358

Tox21_113055

Tox21_113410

U 28508

U-28,508

U-28508

UFUVLHLTWXBHGZ-MGZQPHGTSA-N

UNII-EH6D7113I8

ZINC4102185

US Patents and Regulatory Information for CLINDAGEL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	CLINDAGEL	clindamycin phosphate	GEL;TOPICAL	050782-001	Nov 27, 2000	BT	RX	Yes	Yes			Y

International Patents for CLINDAGEL

Country	Patent Number	Estimated Expiration
Slovenia	2052714
Cyprus	1114646
Brazil	0113247

Supplementary Protection Certificates for CLINDAGEL

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	132013902214376	Italy		PRODUCT NAME: CLINDAMICINA FOSFATO E TRETINOINA(ACNATAC); AUTHORISATION NUMBER(S) AND DATE(S): PA1332/043/001, 20130322;042056010/M - 022/M, 20130718
1304992	CR 2013 00053	Denmark		PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1304992	1390049-3	Sweden		PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322